1. Zur Hausen, H., Papillomaviruses and cancer: from basic studies to clinical application. Nature reviews cancer, 2002. 2(5): p. 342-350.
2. Bosch, F.X., et al., The causal relation between human papillomavirus and cervical cancer. Journal of clinical pathology, 2002. 55(4): p. 244-265.
3. Creuzet, S., et al., Negative effect of Hox gene expression on the development of the neural crest-derived facial skeleton. 2002.
4. Mackenzie, F. and C. Ruhrberg, Diverse roles for VEGF-A in the nervous system. Development, 2012. 139(8): p. 1371-1380.
5. Guidi, A.J., et al., Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. JNCI: Journal of the National Cancer Institute, 1995. 87(16): p. 1237-1245.
6. Lee, I.-J., et al., Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix. International Journal of Radiation Oncology* Biology* Physics, 2002. 54(3): p. 768-779.
7. Toussaint-Smith, E., D.B. Donner, and A. Roman, Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors. Oncogene, 2004. 23(17): p. 2988-2995.
8. Chen, W., et al., Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior. Virology, 2007. 367(1): p. 168-174.
9. Rahman, I., S.K. Biswas, and P.A. Kirkham, Regulation of inflammation and redox signaling by dietary polyphenols. Biochemical pharmacology, 2006. 72(11): p. 1439-1452.
10. Tirkey, N., et al., Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys. BMC pharmacology, 2005. 5(1): p. 1-10.
11. Deeb, D., et al., Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis. Journal of experimental therapeutics & oncology, 2005. 5(2).
12. Tønnesen, H.H. and J. Karlsen, Studies on curcumin and curcuminoids. Zeitschrift für Lebensmittel-Untersuchung und Forschung, 1985. 180(5): p. 402-404.
13. Wang, T.-y. and J.-x. Chen, Effects of curcumin on vessel formation insight into the pro-and antiangiogenesis of curcumin. Evidence-Based Complementary and Alternative Medicine, 2019. 2019.
14. Anand, P., et al., Bioavailability of curcumin: problems and promises. Molecular pharmaceutics, 2007. 4(6): p. 807-818.
15. Shehzad, A., F. Wahid, and Y.S. Lee, Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Archiv der Pharmazie, 2010. 343(9): p. 489-499.
16. Shehzad, A., et al., Curcumin therapeutic promises and bioavailability in colorectal cancer. Drugs of today, 2010. 46(7): p. 523.
17. Shaikh, J., et al., Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. European journal of pharmaceutical sciences, 2009. 37(3-4): p. 223-230.
18. Bisht, S., et al., Polymeric nanoparticle-encapsulated curcumin (" nanocurcumin"): a novel strategy for human cancer therapy. Journal of nanobiotechnology, 2007. 5(1): p. 1-18.
19. Farsani, S.S.M., et al., Nanocurcumin as a novel stimulator of megakaryopoiesis that ameliorates chemotherapy-induced thrombocytopenia in mice. Life Sciences, 2020. 256: p. 117840.
20. TAHMASEBI, B.M., et al., Dendrosomal Nano-curcumin, the Novel Formulation to Improve the Anticancer Properties of Curcumin. 2015.
21. Masters, J.R., HeLa cells 50 years on: the good, the bad and the ugly. Nature Reviews Cancer, 2002. 2(4): p. 315-319.
22. El-Azab, M., et al., Anti-angiogenic effect of resveratrol or curcumin in Ehrlich ascites carcinoma-bearing mice. European journal of pharmacology, 2011. 652(1-3): p. 7-14.
23. Carvalho Ferreira, L., et al., Effect of curcumin on pro-angiogenic factors in the xenograft model of breast cancer. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 2015. 15(10): p. 1285-1296.
24. Pradhan, N., et al., Curcumin nanoparticles inhibit corneal neovascularization. Journal of Molecular Medicine, 2015. 93(10): p. 1095-1106.
25. Li, L., et al., Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Molecular cancer therapeutics, 2007. 6(4): p. 1276-1282.
26. Alizadeh, A.M., et al., Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier–curcumin. European journal of pharmacology, 2012. 689(1-3): p. 226-232.
27. Montazeri, M., et al., Dendrosomal curcumin nanoformulation modulate apoptosis-related genes and protein expression in hepatocarcinoma cell lines. International journal of pharmaceutics, 2016. 509(1-2): p. 244-254.
28. Babaei, E., et al., Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo. International immunopharmacology, 2012. 12(1): p. 226-234.
29. Sadeghzadeh, H., et al., The effects of nanoencapsulated curcumin-Fe3O4 on proliferation and hTERT gene expression in lung cancer cells. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 2017. 17(10): p. 1363-1373.
30. Zaman, M.S., et al., Curcumin nanoformulation for cervical cancer treatment. Scientific reports, 2016. 6(1): p. 1-14.
31. Syng-Ai, C., A.L. Kumari, and A. Khar, Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Molecular cancer therapeutics, 2004. 3(9): p. 1101-1108.
32. Flowers, L.C., et al., Curcumin suppresses growth of cervical cancer cells. 2005, AACR.
33. Ravindran, J., S. Prasad, and B.B. Aggarwal, Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? The AAPS journal, 2009. 11(3): p. 495-510.